A Deep Learning Method to Evaluate QT on Ribociclib

Clinical trial NCT05623397 · COMPLETED

Trial details

NCT number: NCT05623397
Sponsor: CMC Ambroise Paré
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer Ribociclib

Start date: 2023-07-28
Primary completion: 2025-10-08
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.